Previous studies have suggested that in patients undergoing EVT, the adjunctive use of tirofiban following IVT showed a trend toward inferior clinical outcomes compared to the control group, accompanied by an elevated risk of hemorrhage ( 30 ).
← all excerpts
Efficacy and safety of tirofiban for acute ischemic stroke without large and medium vessel occlusion: a systematic review and meta-analysis.
1
—
—